Welcome to LookChem.com Sign In|Join Free
  • or
3-(2-fluorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one is a complex organic chemical compound characterized by its unique molecular structure. 3-(2-fluorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one is a derivative of chalcone, a type of flavonoid, and features a 2-fluorophenyl group attached to the 3-position and a 2-hydroxyphenyl group at the 1-position of the prop-2-en-1-one backbone. The presence of a fluorine atom in the 2-position of the phenyl ring imparts distinct electronic and steric properties to the molecule, which can influence its reactivity and potential applications. The hydroxyl group on the 2-position of the second phenyl ring introduces a site for hydrogen bonding and can affect the compound's solubility and interactions with other molecules. This specific arrangement of functional groups makes 3-(2-fluorophenyl)-1-(2-hydroxyphenyl)prop-2-en-1-one a potentially interesting candidate for further study in various fields, such as pharmaceuticals, materials science, or as a precursor in organic synthesis.

1682-44-6

Post Buying Request

1682-44-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1682-44-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1682-44-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,6,8 and 2 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1682-44:
(6*1)+(5*6)+(4*8)+(3*2)+(2*4)+(1*4)=86
86 % 10 = 6
So 1682-44-6 is a valid CAS Registry Number.

1682-44-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Fluor-2'-hydroxy-chalkon

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1682-44-6 SDS

1682-44-6Relevant academic research and scientific papers

Mycobactin Analogues with Excellent Pharmacokinetic Profile Demonstrate Potent Antitubercular Specific Activity and Exceptional Efflux Pump Inhibition

Shyam, Mousumi,Verma, Harshita,Bhattacharje, Gourab,Mukherjee, Piyali,Singh, Samsher,Kamilya, Sujit,Jalani, Pushpendu,Das, Swetarka,Dasgupta, Arunava,Mondal, Abhishake,Das, Amit Kumar,Singh, Amit,Brucoli, Federico,Bagnéris, Claire,Dickman, Rachael,Basavanakatti, Vinay N.,Naresh Babu, Patibandla,Sankaran, Vadivelan,Dev, Abhimanyu,Sinha, Barij Nayan,Bhakta, Sanjib,Jayaprakash, Venkatesan

, p. 234 - 256 (2022/01/20)

In this study, we have designed and synthesized pyrazoline analogues that partially mimic the structure of mycobactin, to address the requirement of novel therapeutics to tackle the emerging global challenge of antimicrobial resistance (AMR). Our investigation resulted in the identification of novel lead compounds 44 and 49 as potential mycobactin biosynthesis inhibitors against mycobacteria. Moreover, candidates efficiently eradicated intracellularly surviving mycobacteria. Thermofluorimetric analysis and molecular dynamics simulations suggested that compounds 44 and 49 bind to salicyl-AMP ligase (MbtA), a key enzyme in the mycobactin biosynthetic pathway. To the best of our knowledge, these are the first rationally designed mycobactin inhibitors to demonstrate an excellent in vivo pharmacokinetic profile. In addition, these compounds also exhibited more potent whole-cell efflux pump inhibition than known efflux pump inhibitors verapamil and chlorpromazine. Results from this study pave the way for the development of 3-(2-hydroxyphenyl)-5-(aryl)-pyrazolines as a new weapon against superbug-associated AMR challenges.

Spectroscopic analysis by NMR, FT-Raman, ATR-FTIR, and UV-Vis, evaluation of antimicrobial activity, and in silico studies of chalcones derived from 2-hydroxyacetophenone

Xavier, Jayze da Cunha,de Almeida-Neto, Francisco W.Q.,Rocha, Janaína E.,Freitas, Thiago S.,Freitas, Priscila R.,de Araújo, Ana C.J.,da Silva, Priscila T.,Nogueira, Carlos E.S.,Bandeira, Paulo N.,Marinho, Márcia M.,Marinho, Emmanuel S.,Kumar, Nitin,Barreto, Ant?nio C.H.,Coutinho, Henrique D.M.,Juli?o, Murilo S.S.,dos Santos, Hélcio S.,Teixeira, Alexandre M.R.

, (2021/05/31)

Six 2’-hydroxychalcones were synthesized and characterized by NMR, FT-Raman, ATR-FTIR, and UV-Vis. These chalcones alone and in combination with the ciprofloxacin, penicillin, and erythromycin antibiotics were tested against multiresistant strains of Staphylococcus aureus. It was also verified by in vitro and in silico studeis the capacity of these chalcones to inhibit the NorA efflux pump. The MICs values of ciprofloxacin were reduced in the presence of all tested chalcones. For norfloxacin antibiotic, the chalcones A1, A4, A5 and A6 promoted the reduced in the MIC values. The A2 chalcone was the only one to reduce the MIC values when associated with penicillin. Any chalcones were not able to reduce MIC values when associated with erythromycin. These results indicate that the synergistic effects demonstrated for the synthesized chalcones were influenced by the introduction of a furanic ring (A1), a chlorine atom and a methoxy group at the C4 position (A2 and A4), a second double bond (A5), and a fluorine atom at the C2 position (A6). The ADMET analysis predicts that the chalcones A2, A3, A5 and A6 have easier cell permeation. The nucleophilic region makes the A5 chalcone capable of covalently bonding with plasma proteins, and the presence of oxygenated aromatic substitutions makes the chalcones A1 and A4 more water-soluble and consequently easier to excrete. On the other hand, the substitution of the methoxy group of the A4 chalcone makes it more susceptible to O-demethylation reactions by the CYP3A4 isoenzyme. The molecular docking revealed that all six chalcones could hinder the binding of norfloxacin to the NorA efflux pump.

A novel one-pot synthesis of flavones

Chang, Meng-Yang,Tsai, Min-Chen,Lin, Chun-Yi

, p. 11655 - 11662 (2021/03/31)

In this paper, a one-pot facile route for the BiCl3/RuCl3-mediated synthesis of functionalized flavones is described, including: (i) intermolecularortho-acylation of substituted phenols with cinnamoyl chlorides, and (ii) intramolecular cyclodehydrogenation of the resultingo-hydroxychalcones. The reaction conditions are discussed herein.

Substituent-Controlled Divergent Cascade Cycloaddition Reactions of Chalcones and Arylalkynols: Access to Spiroketals and Oxa-Bridged Fused Heterocycles

Chang, Weixing,Kong, Jingyang,Li, Jing,Liu, Lingyan,Wang, Hongkai,Zeng, Tianlong

supporting information, p. 4024 - 4032 (2021/07/12)

Herein, we report substituent-controlled divergent cascade cycloaddition reactions of chalcones and arylalkynols in the presence of PtI2. Depending on the substituent on the chalcone, either spiroketals or oxa-bridged fused heterocycles could be obtained in the ranges of 86–97% and 87–95% yields under identical reaction conditions. Control experiments were carried out to elucidate the origin of the high chemoselectivity. These provide a method for the synthesis of a diverse array of structurally complex oxygen-containing heterocycles. (Figure presented.).

Differences in antioxidant potential of chalcones in human serum: In vitro study

Ivkovi?, Branka,Jankovi?, Tamara,Kotur-Stevuljevi?, Jelena,Turkovi?, Nemanja,Vuji?, Zorica

, (2020/04/17)

Introduction: An imbalance between oxidants and antioxidants in favour of oxidants, potentially leading to damage, is termed oxidative stress. Antioxidants (AO), either enzymatic or non-enzymatic, are the ones that can reduce diverse effects of pro-oxidan

Synthesis and characterization of some new pyrazolines and their inhibitory potencies against carbonic anhydrases

?elik, Gonca,?entürk, Murat,Arslan, Tayfun,Ekinci, Deniz

, (2020/01/21)

The inhibition of the two human cytosolic carbonic anhydrase (hCA; EC 4.2.1.1) isozymes I and II with some new pyrazoline derivatives was investigated for the first time. The structures of the newly synthesized pyrazoline derivatives were characterized by

Temperature-Controlled Stereodivergent Synthesis of 2,2′-Biflavanones Promoted by Samarium Diiodide

Soto, Martín,Soengas, Raquel G.,Silva, Artur M. S.,Gotor-Fernández, Vicente,Rodríguez-Solla, Humberto

supporting information, p. 13104 - 13108 (2019/10/21)

In this work, the first example of a radical stereodivergent reaction directed towards the stereoselective synthesis of both (R*,R*)- and (R*,S*)-2,2′-biflavanones promoted by samarium diiodide is reported. Control experiments showed that the selectivity of this reaction was exclusively controlled by the temperature. It was possible to generate a variety of 2,2′-biflavanones bearing different substitution patterns at the aromatic ring in good-to-quantitative yields, being both stereoisomers of the desired compounds obtained with total or high control of selectivity. A mechanism that explains both the generation of the corresponding 2,2′-biflavanones and the selectivity is also discussed. The structure and stereochemistry determination of each isomer was unequivocally elucidated by single-crystal X-ray diffraction experiments.

Halo-substituted chalcones and azachalcones-inhibited, lipopolysaccharited-stimulated, pro-inflammatory responses through the TLR4-mediated pathway

Shih, Tzenge-Lien,Liu, Ming-Hwa,Li, Chia-Wai,Kuo, Chia-Feng

, (2018/03/21)

A series of B-ring, halo-substituted chalcones and azachalcones were synthesized to evaluate and compare their anti-inflammatory activity. Mouse BALB/c macrophage RAW 264.7 were pre-treated with 10 μg/mL of each compound for one hour before induction of i

Flavone derivatives, preparation method thereof and anticancer agent

-

Paragraph 0169-0173, (2018/05/15)

The present invention relates to a flavone derivative, a manufacturing method thereof and an anticancer agent including the same. Compounds represented by chemical formula 1 and chemical formula 2 according to the present invention are excellent in antica

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1682-44-6